Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus.

Literature DB >> 6327290

The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus.

M D Jones, L Foster, T Sheedy, B E Griffin.

Abstract

Epstein-Barr virus (EBV) DNA isolated from the frequently studied and unusual Burkitt's lymphoma cell line, Daudi, contains a 7.4-kb deletion, similar to (but larger than) that found in a non-transforming isolate of the virus, P3HR-1. A comparison of EBV sequence in Daudi cells with that from a comparable region in a wild-type, transforming strain of the virus (B95-8) indicates that at least two of the previously identified RNAs, a highly repetitive sequence, and other interesting coding or structural features should be absent in Daudi EBV DNA as a consequence of the deletion. The information removed by the deletion, as well as that which might be generated by juxtaposition of two regions of the genome that are not adjacent in most strains of the virus are discussed.

Entities: Chemical

Mesh：

Substances：

Year: 1984 PMID： 6327290 PMCID： PMC557432 DOI： 10.1002/j.1460-2075.1984.tb01890.x

Source DB: PubMed Journal: EMBO J ISSN： 0261-4189 Impact factor: 11.598

51 in total

1. Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors: E M Southern
Journal: J Mol Biol Date: 1975-11-05 Impact factor: 5.469

2. Heterogeneity of Epstein-Barr virus originating from P3HR-1 cells. I. Studies on EBNA induction.

Authors: K O Fresen; B Merkt; G W Bornkamm; H Hausen
Journal: Int J Cancer Date: 1977-03-15 Impact factor: 7.396

3. Complexity of EBV homologous DNA in continous lymphoblastoid cell lines.

Authors: R Pritchett; M Pendersen; E Kieff
Journal: Virology Date: 1976-10-01 Impact factor: 3.616

4. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors: P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal: J Mol Biol Date: 1977-06-15 Impact factor: 5.469

5. Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas.

Authors: L Zech; U Haglund; K Nilsson; G Klein
Journal: Int J Cancer Date: 1976-01-15 Impact factor: 7.396

6. Marker band in one chromosome 14 from Burkitt lymphomas.

Authors: G Manolov; Y Manolova
Journal: Nature Date: 1972-05-05 Impact factor: 49.962

7. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

Authors: E Klein; G Klein; J S Nadkarni; J J Nadkarni; H Wigzell; P Clifford
Journal: Cancer Res Date: 1968-07 Impact factor: 12.701

8. Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon.

Authors: A Adams; H Strander; K Cantell
Journal: J Gen Virol Date: 1975-08 Impact factor: 3.891

9. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference.

Authors: G Miller; J Robinson; L Heston; M Lipman
Journal: Proc Natl Acad Sci U S A Date: 1974-10 Impact factor: 11.205

10. Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line.

Authors: Y Hinuma; M Konn; J Yamaguchi; D J Wudarski; J R Blakeslee; J T Grace
Journal: J Virol Date: 1967-10 Impact factor: 5.103

45 in total

1. Sensitivity of an epstein-barr virus-positive tumor line, Daudi, to alpha interferon correlates with expression of a GC-rich viral transcript.

Authors: Y Gao; S a Xue; B E Griffin
Journal: Mol Cell Biol Date: 1999-11 Impact factor: 4.272

2. Expression of two related viral early genes in Epstein-Barr virus-associated tumors.

Authors: S A Xue; Q L Lu; R Poulsom; L Karran; M D Jones; B E Griffin
Journal: J Virol Date: 2000-03 Impact factor: 5.103

3. Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents.

Authors: Sajal K Ghosh; Susan P Perrine; Robert M Williams; Douglas V Faller
Journal: Blood Date: 2011-12-07 Impact factor: 22.113

4. Characterization of the deletion and rearrangement in the BamHI C region of the X50-7 Epstein-Barr virus genome, a mutant viral strain which exhibits constitutive BamHI W promoter activity.

Authors: C N Yandava; S H Speck
Journal: J Virol Date: 1992-09 Impact factor: 5.103

5. Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells.

Authors: Daniel Salamon; Monika Adori; Dorina Ujvari; Liang Wu; Lorand L Kis; Harsha S Madapura; Noemi Nagy; George Klein; Eva Klein
Journal: J Virol Date: 2012-02-15 Impact factor: 5.103

6. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.

Authors: J Finke; M Rowe; B Kallin; I Ernberg; A Rosén; J Dillner; G Klein
Journal: J Virol Date: 1987-12 Impact factor: 5.103

Review 7. Epstein-Barr virus infection at mucosal surfaces: detection of genomic variants with altered pathogenic potential.

Authors: J W Sixbey; P Shirley
Journal: Springer Semin Immunopathol Date: 1991

8. The LMP1 promoter can be transactivated directly by NF-kappaB.

Authors: Constantinos Demetriades; George Mosialos
Journal: J Virol Date: 2009-03-11 Impact factor: 5.103

9. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

Authors: F Wang; S F Tsang; M G Kurilla; J I Cohen; E Kieff
Journal: J Virol Date: 1990-07 Impact factor: 5.103

10. Epstein-Barr virus latent membrane protein: induction of B-cell activation antigens and membrane patch formation does not require vimentin.

Authors: D Liebowitz; E Kieff
Journal: J Virol Date: 1989-09 Impact factor: 5.103